Response to Becher and Strohner comment regarding Baker DL et al. Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy. CMRO 2014;30:913-22

Autor:	Melissa Cheu, Saloumeh K Fischer, Kun Peng, Dana L. Baker
Rok vydání:	2014
Předmět:	Immunoassay biology business.industry General Medicine Omalizumab Immunoglobulin E Antibodies Monoclonal Humanized Asthma Antibodies Anti-Idiotypic Immunology biology.protein Medicine Humans business medicine.drug
Zdroj:	Current medical research and opinion. 30(10)
ISSN:	1473-4877
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e839e4425adc7094450ea5b49c51d250 https://pubmed.ncbi.nlm.nih.gov/24914579 Zobrazit plný text záznamu